STEM CELL GENE THERAPY USING LONG TERM BONE MARROW CULTURE TRANSDUCTION PROTOCOL
使用长期骨髓培养转导方案的干细胞基因治疗
基本信息
- 批准号:6591288
- 负责人:
- 金额:$ 11.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Attempts to introduce genes into hematopoietic stem cells (HSCs)
have been disappointing In general, using murine retroviral based
vectors to transduce CD34+ cells in vitro have resulted in a low level
(0 1-1%) of gene marking for a limited period of time Studies in
canines demonstrated that LTBMC transduced with retroviral vectors
gave higher levels of gene marking in vivo The advantage of this
technique is that by using unfractionated marrow there is no
preselection; stem cells and retrovirus are able to colocalize on the
stroma; the system selects for LTCIC; transduction occurs 3 times over
21 days following feeding so that cells are in cycle, improving
transduction efficiency We examined the utility of this technique in
rhesus macaques In 2 animals that underwent this autologous
transplantation procedure, no conditioning regime was implemented
Unfractionated marrow was transduced for 15 - 18 days with a PA317LN
based vector Animals were monitored f or "neo" the marker gene in
peripheral blood and bone marrow We observed between 1% and 3% gene
marking in peripheral blood for approximately 3 months The frequency
of neo in bone marrow was generally lower than that in peripheral
blood This technique appears encouraging as our data are similar to
what has been observed by others, but our protocol is in the absence
of any conditioning regimen Recent efforts have focused on attempts to
use LTBMC to transduce HSC using a retroviral vector encoding GFP
Initial experiments using a retroviral vector provided by R Howley
resulted in a failure to maintain LTBMC, which appears to be due to
soluble factors provided by the retroviral producer cell line These
results suggest that the LTBMC technique may be difficult to
generalize to other retroviral vectors Results of these studies may
prove useful in efforts to optimize genetic modification of human
hematopoietic stem cells
将基因导入造血干细胞(HSC)的尝试
总的来说,使用基于鼠逆转录病毒的
体外转染CD 34+细胞的载体导致低水平的
(0 1-1%)的基因标记在有限的时间内的研究
犬证明,用逆转录病毒载体转导的LTBMC
在体内提供了更高水平的基因标记。
这项技术是,通过使用未分级的骨髓,
预选;干细胞和逆转录病毒能够共定位在
基质;系统选择LTCIC;转导发生3次,
喂养后21天,使细胞处于周期中,
转导效率我们检测了这种技术在
恒河猴在2只接受这种自体移植的动物中,
移植过程中,没有实施预处理方案
将未分级的骨髓用PA 317 LN转导15 - 18天,
基于载体的动物监测“neo”标记基因在
外周血和骨髓中,我们观察到1%至3%的基因
在外周血中标记约3个月
neo在骨髓中的表达普遍低于外周血
这种技术似乎令人鼓舞,因为我们的数据与
其他人观察到的情况,但我们的协议是在没有
最近的努力集中在试图
使用编码GFP的逆转录病毒载体将LTBMC用于转染HSC
使用由R Howley提供的逆转录病毒载体的初始实验
导致无法维持LTBMC,这似乎是由于
由逆转录病毒生产细胞系提供的可溶性因子
结果表明,LTBMC技术可能难以
推广到其他逆转录病毒载体这些研究的结果可能
在优化人类基因改造的努力中证明是有用的
造血干细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M ROSENZWEIG其他文献
M ROSENZWEIG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M ROSENZWEIG', 18)}}的其他基金
IN VIVO ANALYSIS OF T CELL TURNOVER IN RHESUS MACAQUES
恒河猴 T 细胞更新的体内分析
- 批准号:
6591317 - 财政年份:2002
- 资助金额:
$ 11.11万 - 项目类别:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
BCL 2 在 SIV 感染的胸腺组织中的表达
- 批准号:
6591316 - 财政年份:2002
- 资助金额:
$ 11.11万 - 项目类别:
FLT LIGAND PERIPHERAL BLOOD STEM CELL MOBILIZATION FOR STEM CELL GENE THERAPY
用于干细胞基因治疗的 FLT 配体外周血干细胞动员
- 批准号:
6591324 - 财政年份:2002
- 资助金额:
$ 11.11万 - 项目类别:
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
异种胸腺移植作为艾滋病治疗的辅助手段
- 批准号:
6591306 - 财政年份:2002
- 资助金额:
$ 11.11万 - 项目类别:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
BCL 2 在 SIV 感染的胸腺组织中的表达
- 批准号:
6453762 - 财政年份:2001
- 资助金额:
$ 11.11万 - 项目类别:
IN VIVO ANALYSIS OF T CELL TURNOVER IN RHESUS MACAQUES
恒河猴 T 细胞更新的体内分析
- 批准号:
6453763 - 财政年份:2001
- 资助金额:
$ 11.11万 - 项目类别:
STEM CELL GENE THERAPY USING LONG TERM BONE MARROW CULTURE TRANSDUCTION PROTOCOL
使用长期骨髓培养转导方案的干细胞基因治疗
- 批准号:
6453734 - 财政年份:2001
- 资助金额:
$ 11.11万 - 项目类别:
FLT LIGAND PERIPHERAL BLOOD STEM CELL MOBILIZATION FOR STEM CELL GENE THERAPY
用于干细胞基因治疗的 FLT 配体外周血干细胞动员
- 批准号:
6453770 - 财政年份:2001
- 资助金额:
$ 11.11万 - 项目类别:
相似海外基金
Molecular mechanisms of animal tissue morphogenesis
动物组织形态发生的分子机制
- 批准号:
572569-2022 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
University Undergraduate Student Research Awards
Feasibility of an integrated ultrasonic enhanced extraction and magneto-immunoassay technique for rapid, in-situ measurement of antibiotic residues in animal tissue
集成超声增强提取和磁免疫分析技术快速原位测量动物组织中抗生素残留的可行性
- 批准号:
131482 - 财政年份:2014
- 资助金额:
$ 11.11万 - 项目类别:
Feasibility Studies
Development of novel fluorescent dye for multiphoton imaging of deep region of animal tissue
开发用于动物组织深部多光子成像的新型荧光染料
- 批准号:
25560411 - 财政年份:2013
- 资助金额:
$ 11.11万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Cell signaling fine-tuning that supports animal tissue development and homeostasis
支持动物组织发育和稳态的细胞信号微调
- 批准号:
25293072 - 财政年份:2013
- 资助金额:
$ 11.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Validation of LC-MS/MS analyses of animal tissue and feed matrices for toxicants
验证动物组织和饲料基质中有毒物质的 LC-MS/MS 分析
- 批准号:
9326829 - 财政年份:2013
- 资助金额:
$ 11.11万 - 项目类别:
Rapid, in-situ measurement of antibiotic residues in animal tissue
快速原位测量动物组织中的抗生素残留
- 批准号:
750767 - 财政年份:2013
- 资助金额:
$ 11.11万 - 项目类别:
Vouchers
Validation of LC-MS/MS analyses of animal tissue and feed matrices for toxicants
验证动物组织和饲料基质中有毒物质的 LC-MS/MS 分析
- 批准号:
8701722 - 财政年份:2013
- 资助金额:
$ 11.11万 - 项目类别:
Validation of LC-MS/MS analyses of animal tissue and feed matrices for toxicants
验证动物组织和饲料基质中有毒物质的 LC-MS/MS 分析
- 批准号:
8908915 - 财政年份:2013
- 资助金额:
$ 11.11万 - 项目类别:
Cellular and molecular mechanisms shaping animal tissue architecture
塑造动物组织结构的细胞和分子机制
- 批准号:
183749-2009 - 财政年份:2013
- 资助金额:
$ 11.11万 - 项目类别:
Discovery Grants Program - Individual
Cellular and molecular mechanisms shaping animal tissue architecture
塑造动物组织结构的细胞和分子机制
- 批准号:
183749-2009 - 财政年份:2012
- 资助金额:
$ 11.11万 - 项目类别:
Discovery Grants Program - Individual